LTS Lohmann Therapie-Systeme AG
LTS receives grant of $1.2 Million to support the development of thermostable mRNA formulations for Microneedle Array Patches
more
Stories from Netanya
-
Language:
English
- Media:
- Period:
- Period:Total
LTS Lohmann Therapie-Systeme AG
LTS expands into large molecule drug delivery with the acquisition of the Sorrel wearable injection device business
Andernach, Germany (ots) - LTS LOHMANN Therapie-Systeme AG (“LTS”), a leading pharmaceutical technology company that develops and manufactures innovative drug delivery systems such as Transdermal Patches (“TTS”), Oral Thin Films (“OTF”) and Micro Array Patches (“MAP”) announces the signing of the ...
moreAquarius Spectrum Announces AQSense-Edge: A New Cat-M/NB-IoT Acoustic Leak Detection Sensor Combined with New AI & UI Improvements
more
1